Home > Newsletters > Washington Drug Letter > Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps
Washington Drug Letter
Aug. 13, 2012 | Vol. 44 No. 32
Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.